Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Tablets in Adult Patients With Allergic Grass Pollen Rhinoconjunctivitis

ClinicalTrials.gov ID: NCT00955825

Public ClinicalTrials.gov record NCT00955825. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 20, 2026, 10:17 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled, Multi-center, Phase III Study of the Efficacy and Safety of 300 IR Sublingual Immunotherapy (SLIT) Administered as Allergen-based Tablets Once Daily to Adult Patients Suffering From Grass Pollen Rhinoconjunctivitis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study is to assess the efficacy and safety of 300 IR sublingual tablet of grass pollen allergen extract compared to placebo in adult patient with allergic rhinoconjunctivitis.

Study identification

NCT ID
NCT00955825
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Stallergenes Greer
Industry
Enrollment
473 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 2008 (Type not available)
Primary completion
Aug 2009 (Actual)
Completion
Aug 2009 (Actual)
Last update posted
May 19, 2016

2008 – 2009

United States locations

U.S. sites
19
U.S. states
12
U.S. cities
19
Facility City State ZIP Site status
Sneeze, wheeze, and Itch Associates, LLC Normal Illinois 61761 —
University of Kentucky Medical Center Lexington Kentucky 40508 —
Allergy & Asthma Specialists, PSC Owensboro Kentucky 42301 —
Johns Hopkins University Baltimore Maryland 21224 —
Respiratory Medical Research Institute of Michigan PLC Ypsilanti Michigan 48197 —
Clinical Research of the Ozarks, Inc. Columbia Missouri 65203 —
Midwest Clinical Research LLC St Louis Missouri 63141 —
Clinical Research of the Ozarks, Inc Warrensburg Missouri 64093 —
Montana Allergy & Asthma Specialists Billings Montana 59101 —
Montana Medical Research Missoula Montana 59808 —
Creighton University - Allergy & Asthma Omaha Nebraska 68131 —
Bernstein Clinical Research Center, LLC Cincinnati Ohio 45231 —
Allergy and Asthma Research Group Eugene Oregon 97401 —
Baker Allergy, Asthma, & Dermatology Research Center, LLC Lake Oswego Oregon 97035 —
Clinical Research Institute of Southern Oregon, P.C. Medford Oregon 97504 —
Allergy Associates Research Portland Oregon 97213 —
Allergy & Clinical Immunology Associates Pittsburgh Pennsylvania 15241 —
Vanderbilt University Medical Center Nashville Tennessee 37203 —
North West Asthma Allergy Center Vancouver Washington 98664 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00955825, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 19, 2016 · Synced Oct 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00955825 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →